134 related articles for article (PubMed ID: 27060453)
1. Inhibition of NF-κB and metastasis in irinotecan (CPT-11)-resistant LoVo colon cancer cells by thymoquinone via JNK and p38.
Chen MC; Lee NH; Hsu HH; Ho TJ; Tu CC; Chen RJ; Lin YM; Viswanadha VP; Kuo WW; Huang CY
Environ Toxicol; 2017 Feb; 32(2):669-678. PubMed ID: 27060453
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cancer via mitochondrial dysfunction and activation of JNK and p38.
Chen MC; Lee NH; Hsu HH; Ho TJ; Tu CC; Hsieh DJ; Lin YM; Chen LM; Kuo WW; Huang CY
J Agric Food Chem; 2015 Feb; 63(5):1540-6. PubMed ID: 25611974
[TBL] [Abstract][Full Text] [Related]
3. Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells.
Chen MC; Lee NH; Ho TJ; Hsu HH; Kuo CH; Kuo WW; Lin YM; Tsai FJ; Tsai CH; Huang CY
Cancer Lett; 2014 Jul; 349(1):51-60. PubMed ID: 24726344
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation.
Hsu HH; Chen MC; Day CH; Lin YM; Li SY; Tu CC; Padma VV; Shih HN; Kuo WW; Huang CY
World J Gastroenterol; 2017 Feb; 23(7):1171-1179. PubMed ID: 28275297
[TBL] [Abstract][Full Text] [Related]
6. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Hwang YP; Yun HJ; Choi JH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):977-90. PubMed ID: 19943262
[TBL] [Abstract][Full Text] [Related]
7. The role of p38 in irinotecan-induced DNA damage and apoptosis of colon cancer cells.
Rudolf E; Kralova V; Rudolf K; John S
Mutat Res; 2013; 741-742():27-34. PubMed ID: 23422270
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling.
El-Najjar N; Chatila M; Moukadem H; Vuorela H; Ocker M; Gandesiri M; Schneider-Stock R; Gali-Muhtasib H
Apoptosis; 2010 Feb; 15(2):183-95. PubMed ID: 19882352
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone inhibits phorbol ester-induced activation of NF-κB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo.
Kundu JK; Liu L; Shin JW; Surh YJ
Biochem Biophys Res Commun; 2013 Sep; 438(4):721-7. PubMed ID: 23911786
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
[TBL] [Abstract][Full Text] [Related]
11. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
[TBL] [Abstract][Full Text] [Related]
12. Camptothecin suppresses expression of matrix metalloproteinase-9 and vascular endothelial growth factor in DU145 cells through PI3K/Akt-mediated inhibition of NF-κB activity and Nrf2-dependent induction of HO-1 expression.
Jayasooriya RG; Park SR; Choi YH; Hyun JW; Chang WY; Kim GY
Environ Toxicol Pharmacol; 2015 May; 39(3):1189-98. PubMed ID: 25941985
[TBL] [Abstract][Full Text] [Related]
13. Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cells.
Togano T; Sasaki M; Watanabe M; Nakashima M; Tsuruo T; Umezawa K; Higashihara M; Watanabe T; Horie R
Biochem Biophys Res Commun; 2009 Dec; 390(1):60-4. PubMed ID: 19778522
[TBL] [Abstract][Full Text] [Related]
14. Taiwanin E inhibits cell migration in human LoVo colon cancer cells by suppressing MMP-2/9 expression via p38 MAPK pathway.
Hsu HH; Kuo WW; Day CH; Shibu MA; Li SY; Chang SH; Shih HN; Chen RJ; Viswanadha VP; Kuo YH; Huang CY
Environ Toxicol; 2017 Aug; 32(8):2021-2031. PubMed ID: 27807932
[TBL] [Abstract][Full Text] [Related]
15. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-kappaB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding.
Darieva Z; Lasunskaia EB; Campos MN; Kipnis TL; Da Silva WD
J Leukoc Biol; 2004 Apr; 75(4):689-97. PubMed ID: 14742634
[TBL] [Abstract][Full Text] [Related]
16. [Anti-metastasis effect of thymoquinone on human pancreatic cancer].
Wu ZH; Chen Z; Shen Y; Huang LL; Jiang P
Yao Xue Xue Bao; 2011 Aug; 46(8):910-4. PubMed ID: 22007514
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
18. Epicatechin gallate induces cell death via p53 activation and stimulation of p38 and JNK in human colon cancer SW480 cells.
Cordero-Herrera I; Martín MA; Bravo L; Goya L; Ramos S
Nutr Cancer; 2013; 65(5):718-28. PubMed ID: 23859040
[TBL] [Abstract][Full Text] [Related]
19. Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.
Paillas S; Boissière F; Bibeau F; Denouel A; Mollevi C; Causse A; Denis V; Vezzio-Vié N; Marzi L; Cortijo C; Ait-Arsa I; Askari N; Pourquier P; Martineau P; Del Rio M; Gongora C
Cancer Res; 2011 Feb; 71(3):1041-9. PubMed ID: 21159664
[TBL] [Abstract][Full Text] [Related]
20. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
